| (210) | Number of the EPO application | 16756950 |
| (220) | Filing date of the EPO application | 2016.08.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2021, 2021.06.23 |
| (110) | EPO patent number | 3328889 |
| (11) | Number of the document | MD 3328889 T2 |
| (21) | Number of the application | e 2018 0562 |
| (71) | Name(s) of applicant(s), code of the country | Amgen Research (Munich) GmbH, DE; |
| (72) | Name(s) of inventor(s), code of the country | RAUM Tobias, DE;
KUFER Peter, DE;
PENDZIALEK Jochen, DE;
BLUEMEL Claudia, DE;
DAHLHOFF Christoph, DE;
HOFFMANN Patrick, DE;
LUTTERBUESE Ralf, DE;
NAHRWOLD Elisabeth, DE; |
| (73) | Name(s) of owner(s), code of the country | AMGEN Research (Munich) GmbH, DE; |
| (54) | Title of the invention | Bispecific antibody constructs binding dll3 and cd3 |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2018.07.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.10.31 |
| (30) | Priority | 201562199930 P, 2015.07.31, US; 201662290896 P, 2016.02.03, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2016/068285, 2016.08.01 |
| (87) | International publication | WO 2017/021349, 2017.02.09 |